MitMAB (SKU B7620): Reliable Dynamin Inhibition for Organoid
2026-08-03
This article offers scenario-driven, data-backed guidance for scientists using MitMAB (SKU B7620) to address reproducibility and mechanistic clarity in endocytosis and cellular uptake assays. Each section explores practical lab challenges—like model compatibility, assay optimization, and vendor selection—demonstrating how MitMAB's specificity and purity empower robust, interpretable results in organoid and cell-based workflows.
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S
2026-08-03
This study introduces a novel patient-derived gastric cancer assembloid model that integrates organoids with matched stromal cell subpopulations, closely recapitulating the tumor microenvironment. The assembloid platform enhances the physiological relevance of preclinical drug screening and provides new insights into resistance mechanisms and personalized therapy development.
RCN2 Drives ESCC Metastasis and Chemoresistance via PI3K-AKT
2026-08-02
This study identifies reticulocalbin 2 (RCN2) as a key promoter of metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-mediated degradation of PPP2CA and consequent activation of the PI3K-AKT pathway. The findings highlight a novel molecular axis and therapeutic target for combating aggressive ESCC phenotypes.
BMS 599626 dihydrochloride: Potent EGFR and ErbB2 Inhibitor
2026-08-01
BMS 599626 dihydrochloride is a nanomolar-range EGFR and ErbB2 inhibitor that suppresses cancer cell proliferation and tumor growth in vivo. It is widely utilized in breast and lung cancer research for dissecting receptor-driven oncogenic signaling. This article details its mechanism, benchmarks, and integration in translational workflows.
4-Phenylbutyric Acid: Advanced Strategies for ER Stress Assa
2026-07-31
Explore how 4-Phenylbutyric acid (4-PBA) enables advanced, reproducible ER stress alleviation in cell models. This article uniquely bridges molecular mechanism, recent assay innovations, and reference-driven protocol insights for rigorous apoptosis and autophagy research.
Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work
2026-07-31
Cy5 NHS ester(Et) is a water-soluble fluorescent dye optimized for covalent labeling of primary amine groups in proteins and biomolecules, supporting applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not compatible with ethanol-based protocols or long-term storage of labeling solutions, and requires strict adherence to dissolution and handling guidelines for optimal performance.
Carboxylesterase Interference in Amplex Red H2O2 Assays: Imp
2026-07-30
Miwa et al. (2016) demonstrated that carboxylesterases can convert Amplex Red to resorufin independently of hydrogen peroxide, leading to significant overestimation of mitochondrial H2O2 release in commonly used assays. These findings highlight a critical methodological pitfall in reactive oxygen species measurement and suggest the need for revised protocols in oxidative stress research.
Fulvestrant (ICI 182,780): Applied Workflows in Breast Cance
2026-07-30
Fulvestrant (ICI 182,780) stands out as a gold-standard ER antagonist, driving both apoptosis and enhanced chemotherapy sensitivity in advanced breast cancer models. This article delivers actionable protocols, troubleshooting tactics, and translational strategies to maximize research impact with APExBIO’s Fulvestrant.
CTOP in Mechanistic Opioid Research: Beyond Receptor Antagon
2026-07-29
Explore how CTOP, a selective μ-opioid receptor antagonist, advances mechanistic opioid signaling research with unprecedented clarity. This article uniquely connects circuit-level discoveries to practical assay choices for pain and neuropharmacology studies.
Peroxidasin Enhances Glycolysis and Malignancy in Glioblasto
2026-07-29
This study identifies peroxidasin (PXDN) as a critical modulator of glycolytic metabolism in glioblastoma, acting through the regulation of LDHA to promote tumor progression. The findings highlight PXDN as a promising diagnostic biomarker and potential therapeutic target for glioblastoma, with implications for energy metabolism assay development.
ARCA Cy3 EGFP mRNA (5-moUTP): Mechanisms, Innovations, and A
2026-07-28
Explore the advanced mechanisms and assay advantages of ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, for high-fidelity fluorescent mRNA delivery and localization studies. This article dissects the science behind its unique features and practical implications for translational research.
Protease Inhibitor Cocktail: Enhancing Protein Stability in
2026-07-28
The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO empowers high-fidelity lipid droplet metabolism studies by preserving labile protein complexes during extraction. Discover tested workflows, troubleshooting strategies, and unique advantages that differentiate this protease inhibitor mixture for advanced DFCP1-ATGL axis research.
Clodronate Liposomes: Redefining Macrophage Function in Agin
2026-07-27
Explore how Clodronate Liposomes empower precise in vivo macrophage depletion, with a special focus on aging models and mitochondrial redox regulation. Uncover unique assay considerations and actionable insights for advanced immune cell studies.
Steroid-Induced Protoplast Lysis: Mechanism and Research Imp
2026-07-27
Smith and Shay’s 1965 study introduced a protoplast-based approach to dissect the membrane-disruptive effects of synthetic steroids, revealing that direct action on microbial membranes, rather than cell wall exclusion, underpins their antimicrobial activity. These insights continue to inform the design of mechanistic assays and the interpretation of polyene antifungal antibiotic effects in fungal infection research.
Ketamine's Immunomodulation in LPS-Induced Depression: mTOR
2026-07-26
This study demonstrates that ketamine alleviates depressive-like behavior in mice through immunomodulatory effects, notably reducing microglial activation and brain monocyte infiltration. Importantly, the work links ketamine’s antidepressant actions to mTOR signaling, with implications for targeted intervention in inflammation-associated depression.
464 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page